시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 고분자 바이오 분석 기술 시장 보고서(2025년)
Large Molecule Bioanalytical Technologies Global Market Report 2025
상품코드 : 1825785
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,471,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,354,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,236,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

고분자 바이오 분석 기술 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 연평균 13.4%의 CAGR로 192억 8,000만 달러로 성장할 것입니다. 예측 기간의 성장은 바이오의약품 수요 증가, 생명과학 연구 투자 확대, 현장 검사 수요 증가, 만성질환 유병률 증가, 생물학적 제제 및 바이오시밀러 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 실시간 분석, 품질 관리 실험실 채택, 인공지능 통합, 기술 발전, 클라우드 기반 솔루션 채택, 디지털 기술 채택 등이 있습니다.

향후 5년간 13.4%의 성장률 전망은 지난번 예측보다 0.5% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 장벽은 영국과 독일에서 조달하는 생물학적 특성평가용 질량분석 시스템 및 크로마토그래피 컬럼의 비용을 상승시킴으로써 미국을 저해하고, 바이오 치료제 개발을 지연시키며, 분석 실험실의 비용을 상승시킬 것으로 예상됩니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

맞춤형 의료에 대한 관심이 높아짐에 따라 고분자 바이오 분석 기술 시장의 성장이 크게 촉진될 것으로 예상됩니다. 개인맞춤의료란 유전적 체질, 바이오마커, 생활습관, 환경적 요인 등 환자 개개인의 특성에 맞게 치료와 건강관리를 결정하여 효과를 최적화하고 부작용을 최소화하는 것을 말합니다. 개인별 질병 감수성 차이, 가치 기반 의료로의 전환, 환자 중심 치료의 중요성 등의 요인이 맞춤형 의료에 대한 집중을 촉진하고 있습니다. 고분자 바이오 분석기술은 의약품 개발에 있어 단클론항체, 유전자 치료제 등 고분자 의약품의 약동학 및 약력학을 특성화하기 위해 필수적인 기술입니다. 예를 들어, 2024년 2월, 개인맞춤의료연합(Personalized Medicine Coalition)은 FDA가 2023년 희귀질환 환자를 위한 16개의 새로운 맞춤형 의약품을 승인했으며, 이는 2022년 6개에서 증가했다고 보고했습니다. 이러한 추세는 맞춤형 의료의 중요성을 강조하며 첨단 바이오 분석 기술에 대한 수요를 촉진하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

KSM
영문 목차

영문목차

Large molecule bioanalytical technologies encompass analytical methods used to examine and evaluate complex biological entities such as proteins and nucleic acids. These technologies are crucial for understanding the structure, functionality, and interactions of these molecules, playing a vital role in drug discovery, clinical diagnostics, and biotechnology research.

The primary categories in the large molecule bioanalytical technologies market include products and services. Products consist of physical items such as instruments, consumables, software, and accessories utilized for the analysis and manipulation of large biological molecules. These technologies encompass a range of methods, including chromatography, mass spectrometry, enzyme-linked immunosorbent assay (ELISA), electrophoresis, polymerase chain reaction (PCR), western blot, flow cytometry, spectrometry, and others. These are applied in various fields such as biologics, oligonucleotide-derived drugs and molecules, viral vectors, cell and gene therapy, nanoparticles and polymers, and disease diagnosis, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The large molecule bioanalytical technologies market research report is one of a series of new reports from The Business Research Company that provides large molecule bioanalytical technologies market statistics, including large molecule bioanalytical technologies industry global market size, regional shares, competitors with a large molecule bioanalytical technologies market share, detailed large molecule bioanalytical technologies market segments, market trends and opportunities, and any further data you may need to thrive in the large molecule bioanalytical technologies industry. This large molecule bioanalytical technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The large molecule bioanalytical technologies market size has grown rapidly in recent years. It will grow from $10.19 billion in 2024 to $11.67 billion in 2025 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to increasing investment in biotechnology research, growth of proteomics research, growth in high-throughput screening, increasing adoption of next-generation sequencing, increasing adoption of single-cell analysis.

The large molecule bioanalytical technologies market size is expected to see rapid growth in the next few years. It will grow to $19.28 billion in 2029 at a compound annual growth rate (CAGR) of 13.4%. The growth in the forecast period can be attributed to increasing demand for biopharmaceuticals, growing investment in life sciences research, increasing demand for point-of-care testing, increasing prevalence of chronic diseases, increasing demand for biologics and biosimilars. Major trends in the forecast period include real-time analysis, adoption of quality control labs, integration of artificial intelligence, technological advancements, adoption of cloud-based solutions, adoption of digital technologies.

The forecast of 13.4% growth over the next five years reflects a modest reduction of 0.5% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S.by increasing the cost of mass spectrometry systems and chromatography columns for biologic characterization sourced from the UK and Germany, thereby slowing biotherapeutic development and elevating analytical laboratory costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing focus on personalized medicine is expected to significantly drive the growth of the large molecule bioanalytical technologies market. Personalized medicine involves tailoring medical treatment and healthcare decisions to individual patient characteristics, including genetic makeup, biomarkers, lifestyle, and environmental factors, to optimize efficacy and minimize side effects. Factors such as individual variability in disease susceptibility, the shift towards value-based healthcare, and the emphasis on patient-centered care are propelling the focus on personalized medicine. Large-molecule bioanalytical technologies are essential in drug development for characterizing the pharmacokinetics and pharmacodynamics of large-molecule drugs, such as monoclonal antibodies and gene therapies. For instance, in February 2024, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized medicines for rare disease patients in 2023, up from six in 2022. This trend underscores the growing importance of personalized medicine and drives the demand for advanced bioanalytical technologies.

Leading companies in the large molecule bioanalytical technologies market are developing advanced technologies to enhance the analysis and characterization of large molecules. For example, Fourier transform infrared (FTIR) spectroscopy is a sophisticated technique used to determine the chemical structure of biomolecules. In April 2022, Edinburgh Instruments Ltd. launched the IR5, a benchtop FTIR spectrometer designed for molecular spectroscopy applications. The IR5 offers high sensitivity and spectral resolution, an additional detector for improved sensitivity, and the ability to perform combined absorption and photoluminescence spectroscopy. The instrument is equipped with Miracle software, providing a modern and intuitive user experience.

In December 2022, Reaction Biology, a biotechnology research company based in the US, acquired Bioassay GmbH for an undisclosed amount. The acquisition is intended to strengthen Reaction Biology's preclinical drug discovery capabilities by integrating Bioassay GmbH's expertise in biochemical and cell-based assays. Bioassay GmbH is a Germany-based company specializing in bioanalytical assays.

Major companies operating in the large molecule bioanalytical technologies market are Thermo Fisher Scientific Inc., Danaher Corporation, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Charles River Laboratories International Inc., Intertek Group plc, Shimadzu Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., HORIBA Ltd., SCIEX, Bio-Techne Corporation, Hamilton Company, Promega Corporation, Verder Group, Solvias AG, Analytik Jena AG, Genedata AG, Wyatt Technology Corporation, Nanalysis Corporation, Avomeen Analytical Services, Cergentis B.V., Halo Labs Inc., Hitachi High-Technologies Corporation, Precision NanoSystems Inc.

North America was the largest region in the large molecule bioanalytical technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the large molecule bioanalytical technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the large molecule bioanalytical technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The large molecule bioanalytical technologies market consists of revenues earned by entities by providing services such as analytical testing services, assay development services, and outsourcing services. The market value includes the value of related goods sold by the service provider or included within the service offering. The large molecule bioanalytical technologies market also includes sales of spectrophotometers, pipettes, and microplate readers. values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Large Molecule Bioanalytical Technologies Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on large molecule bioanalytical technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for large molecule bioanalytical technologies ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The large molecule bioanalytical technologies market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

1) By Products - Instruments ( Mass Spectrometers, Chromatography Systems, Immunoassay Analyzers); Reagents And Consumables ( Antibodies, Enzyme-Linked Immunosorbent Assay (Elisa) Kits); Software ( Data Analysis And Visualization Software)

2) By Services - Analytical Testing Services; Contract Research Organization (Cro) Services; Method Development And Validation Services; Stability Testing Services; Consulting And Training Services

Table of Contents

1. Executive Summary

2. Large Molecule Bioanalytical Technologies Market Characteristics

3. Large Molecule Bioanalytical Technologies Market Trends And Strategies

4. Large Molecule Bioanalytical Technologies Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Large Molecule Bioanalytical Technologies Growth Analysis And Strategic Analysis Framework

6. Large Molecule Bioanalytical Technologies Market Segmentation

7. Large Molecule Bioanalytical Technologies Market Regional And Country Analysis

8. Asia-Pacific Large Molecule Bioanalytical Technologies Market

9. China Large Molecule Bioanalytical Technologies Market

10. India Large Molecule Bioanalytical Technologies Market

11. Japan Large Molecule Bioanalytical Technologies Market

12. Australia Large Molecule Bioanalytical Technologies Market

13. Indonesia Large Molecule Bioanalytical Technologies Market

14. South Korea Large Molecule Bioanalytical Technologies Market

15. Western Europe Large Molecule Bioanalytical Technologies Market

16. UK Large Molecule Bioanalytical Technologies Market

17. Germany Large Molecule Bioanalytical Technologies Market

18. France Large Molecule Bioanalytical Technologies Market

19. Italy Large Molecule Bioanalytical Technologies Market

20. Spain Large Molecule Bioanalytical Technologies Market

21. Eastern Europe Large Molecule Bioanalytical Technologies Market

22. Russia Large Molecule Bioanalytical Technologies Market

23. North America Large Molecule Bioanalytical Technologies Market

24. USA Large Molecule Bioanalytical Technologies Market

25. Canada Large Molecule Bioanalytical Technologies Market

26. South America Large Molecule Bioanalytical Technologies Market

27. Brazil Large Molecule Bioanalytical Technologies Market

28. Middle East Large Molecule Bioanalytical Technologies Market

29. Africa Large Molecule Bioanalytical Technologies Market

30. Large Molecule Bioanalytical Technologies Market Competitive Landscape And Company Profiles

31. Large Molecule Bioanalytical Technologies Market Other Major And Innovative Companies

32. Global Large Molecule Bioanalytical Technologies Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Large Molecule Bioanalytical Technologies Market

34. Recent Developments In The Large Molecule Bioanalytical Technologies Market

35. Large Molecule Bioanalytical Technologies Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기